Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
about
Evaluation of protein biomarkers of prostate cancer aggressivenessControl of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivoAntiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cellsExpression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patientsDeletion and down-regulation of SMAD4 gene in colorectal cancers in a Chinese population.Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors.Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer.Species-specific cis-regulatory elements in the 3'-untranslated region direct alternative polyadenylation of bone morphogenetic protein 2 mRNA.Defective pulmonary vascular remodeling in Smad8 mutant miceProstate cancer: the need for biomarkers and new therapeutic targets.Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression.Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft.BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression.The Dual Role of Bone Morphogenetic Proteins in Cancer.Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer.Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis.
P2860
Q21261257-A7CCA732-4435-4FFB-A437-6B33833C24A4Q24337748-33B02255-12A4-4ED9-821A-4D33F32F10CAQ30487367-0386C67B-FEE8-4687-B092-07A816D0521BQ33295288-78D11BEA-8138-444A-B815-BB1DA10A9E3BQ33509737-6803BAEA-5EC0-43A0-89EA-518DC6D122B1Q34008631-563EEC92-3A9B-4EE4-BA7B-5CEF5B669A24Q34452747-DF0696F1-37ED-4B14-8713-338523EA7E0DQ35915965-05039F32-C4EC-43A3-B806-CD5D56169002Q36421055-144B9EC6-7760-48E0-BEB6-ABC4F89183EDQ36889693-E7A1B34E-750B-4588-B8C4-21345E191EEDQ37141487-F69818FE-D962-4DDA-86D7-96D643337529Q37252723-1EF40BA2-7078-44F8-ACEF-97C1548EA33DQ37476043-749CF2D5-F241-42FB-9480-3D92CBD4D308Q37650697-2BFE0272-9A3E-4B33-A1E0-0C857BFED05CQ38923285-E37242FC-62DF-416C-97B7-DA449D76D7B4Q38928611-EB4D7B59-3FE8-447C-B9D0-ED8F5FEF8428Q39443306-55B82E3C-C201-4EC0-A6CF-55DEDB93DC0BQ42695596-4C31B476-2628-42BE-B8BC-5CD37F875D76Q46063070-48E5F30E-42F8-4CF0-A353-85365F4BDFB5Q47097550-566D7C89-D1E5-4B71-B390-D229346AEF36Q47163689-3DF472D4-6526-47B4-813B-D2AD5D19F46DQ48288989-D7178CF7-370C-4677-8F66-1D9FD84BBFC5Q55714340-83707CFF-6430-4859-B3E7-F7481D485E8A
P2860
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
@en
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
@nl
type
label
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
@en
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
@nl
prefLabel
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
@en
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
@nl
P2093
P2860
P50
P356
P1433
P1476
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression
@en
P2093
David Golovsky
Gordon F O'Neill
John J Grygiel
Phillip C Brenner
Phillip D Stricker
Raji Kooner
Robert L Sutherland
Susan M Henshall
P2860
P304
P356
10.1002/PROS.10361
P577
2004-05-01T00:00:00Z